Tinavi Medical Technologies Co Ltd
Tinavi Medical Technologies Co.,Ltd. engages in the research and development, production, sale, market, service, and clinical application of orthopedic surgery robots and related technologies. The company offers TiRobot II, an orthopedic robotic system to create an operation center; TiRobot, an orthopedic robotic system used in implants in surgery for spine and trauma; 5G remote surgery systems; … Read more
Tinavi Medical Technologies Co Ltd (688277) - Net Assets
Latest net assets as of September 2025: CN¥1.29 Billion CNY
Based on the latest financial reports, Tinavi Medical Technologies Co Ltd (688277) has net assets worth CN¥1.29 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.78 Billion) and total liabilities (CN¥484.88 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.29 Billion |
| % of Total Assets | 72.71% |
| Annual Growth Rate | 40.83% |
| 5-Year Change | 24.7% |
| 10-Year Change | 527.57% |
| Growth Volatility | 97.87 |
Tinavi Medical Technologies Co Ltd - Net Assets Trend (2013–2024)
This chart illustrates how Tinavi Medical Technologies Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Tinavi Medical Technologies Co Ltd (2013–2024)
The table below shows the annual net assets of Tinavi Medical Technologies Co Ltd from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.28 Billion | +3.44% |
| 2023-12-31 | CN¥1.24 Billion | +10.73% |
| 2022-12-31 | CN¥1.12 Billion | +4.68% |
| 2021-12-31 | CN¥1.07 Billion | +4.00% |
| 2020-12-31 | CN¥1.03 Billion | +72.14% |
| 2019-12-31 | CN¥596.34 Million | +6.37% |
| 2018-12-31 | CN¥560.61 Million | +230.92% |
| 2017-12-31 | CN¥169.41 Million | +24.00% |
| 2016-12-31 | CN¥136.62 Million | -33.02% |
| 2015-12-31 | CN¥203.98 Million | +286.03% |
| 2014-12-31 | CN¥52.84 Million | +78.49% |
| 2013-12-31 | CN¥29.60 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Tinavi Medical Technologies Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 54912961332.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CN¥449.39 Million | 35.45% |
| Other Comprehensive Income | CN¥391.05 Million | 30.84% |
| Other Components | CN¥979.32 Million | 77.24% |
| Total Equity | CN¥1.27 Billion | 100.00% |
Tinavi Medical Technologies Co Ltd Competitors by Market Cap
The table below lists competitors of Tinavi Medical Technologies Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jiangsu Toland Alloy Co Ltd
SHE:300855
|
$1.09 Billion |
|
Jiangsu Eazytec Co Ltd
SHG:688258
|
$1.09 Billion |
|
JHT Design Co. Ltd. Cl A
SHG:603061
|
$1.09 Billion |
|
CRAYON GROUP HOLDING NK 1
F:30X
|
$1.09 Billion |
|
Vicat S.A.
PA:VCT
|
$1.09 Billion |
|
Lifestance Health Group Inc
NASDAQ:LFST
|
$1.09 Billion |
|
Shanghai Zhongyida Co Ltd A
SHG:600610
|
$1.09 Billion |
|
Smithfield Foods, Inc. Common Stock
NASDAQ:SFD
|
$1.08 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Tinavi Medical Technologies Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,237,523,025 to 1,267,845,501, a change of 30,322,476 (2.5%).
- Net loss of 121,129,687 reduced equity.
- Dividend payments of 9,061,359 reduced retained earnings.
- Other comprehensive income increased equity by 131,473,330.
- Other factors increased equity by 29,040,192.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-121.13 Million | -9.55% |
| Dividends Paid | CN¥9.06 Million | -0.71% |
| Other Comprehensive Income | CN¥131.47 Million | +10.37% |
| Other Changes | CN¥29.04 Million | +2.29% |
| Total Change | CN¥- | 2.45% |
Book Value vs Market Value Analysis
This analysis compares Tinavi Medical Technologies Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 8.63x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 24.34x to 8.63x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CN¥0.99 | CN¥23.99 | x |
| 2014-12-31 | CN¥1.74 | CN¥23.99 | x |
| 2015-12-31 | CN¥1.07 | CN¥23.99 | x |
| 2016-12-31 | CN¥0.91 | CN¥23.99 | x |
| 2017-12-31 | CN¥0.95 | CN¥23.99 | x |
| 2018-12-31 | CN¥1.78 | CN¥23.99 | x |
| 2019-12-31 | CN¥1.40 | CN¥23.99 | x |
| 2020-12-31 | CN¥2.38 | CN¥23.99 | x |
| 2021-12-31 | CN¥2.40 | CN¥23.99 | x |
| 2022-12-31 | CN¥2.49 | CN¥23.99 | x |
| 2023-12-31 | CN¥2.77 | CN¥23.99 | x |
| 2024-12-31 | CN¥2.78 | CN¥23.99 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Tinavi Medical Technologies Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -9.55%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -67.73%
- • Asset Turnover: 0.11x
- • Equity Multiplier: 1.33x
- Recent ROE (-9.55%) is below the historical average (-6.22%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 21.30% | 15.10% | 1.01x | 1.40x | CN¥3.35 Million |
| 2014 | -29.83% | -40.66% | 0.58x | 1.27x | CN¥-21.05 Million |
| 2015 | -9.37% | -64.44% | 0.11x | 1.29x | CN¥-31.94 Million |
| 2016 | -18.83% | -100.59% | 0.14x | 1.36x | CN¥-39.39 Million |
| 2017 | 13.67% | 29.56% | 0.12x | 3.93x | CN¥5.82 Million |
| 2018 | -0.16% | -0.68% | 0.19x | 1.20x | CN¥-55.94 Million |
| 2019 | -5.29% | -13.49% | 0.32x | 1.22x | CN¥-89.49 Million |
| 2020 | -5.47% | -40.08% | 0.12x | 1.12x | CN¥-154.07 Million |
| 2021 | -7.94% | -51.23% | 0.12x | 1.27x | CN¥-180.63 Million |
| 2022 | -10.60% | -70.80% | 0.11x | 1.35x | CN¥-214.95 Million |
| 2023 | -12.64% | -74.46% | 0.13x | 1.31x | CN¥-280.14 Million |
| 2024 | -9.55% | -67.73% | 0.11x | 1.33x | CN¥-247.91 Million |
Industry Comparison
This section compares Tinavi Medical Technologies Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,246,530,775
- Average return on equity (ROE) among peers: 12.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Tinavi Medical Technologies Co Ltd (688277) | CN¥1.29 Billion | 21.30% | 0.38x | $1.09 Billion |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $2.03 Billion | -9.26% | 2.64x | $356.80 Million |
| Blue Sail Medical Co Ltd (002382) | $10.54 Billion | 10.97% | 0.61x | $763.05 Million |
| Andon Health Co Ltd (002432) | $758.75 Million | 1.34% | 0.32x | $2.12 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $2.75 Billion | 15.67% | 0.82x | $346.13 Million |
| Guangzhou Improve Med Instrument (300030) | $592.55 Million | 4.90% | 0.10x | $234.74 Million |
| Shanghai Tofflon Science Tech (300171) | $2.41 Billion | 11.06% | 0.57x | $784.88 Million |
| Truking Technology Ltd (300358) | $320.32 Million | 29.77% | 1.35x | $545.42 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $1.41 Billion | 16.14% | 0.58x | $438.45 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $1.55 Billion | 13.64% | 0.15x | $1.62 Billion |
| Autek China Inc (300595) | $105.24 Million | 28.59% | 0.10x | $1.21 Billion |